Back
Arcus Biosciences Stock Price Chart
Sponsored
RCUS
Sponsored
Billionaire Investors Join Forces to Fund Next Generation
Learn More
Buy
72
RCUS
Arcus Biosciences
Last Price:
18.22
Seasonality Move:
18.13%
7 Day Trial
ALL ACCESS PASS
$
7
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free Report- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Arcus Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.13 | Buy |
20-day SMA: | 18.12 | Buy |
50-day SMA: | 17.05 | Buy |
200-day SMA: | 17.91 | Buy |
8-day EMA: | 17.38 | Buy |
20-day EMA: | 17.68 | Buy |
50-day EMA: | 17.48 | Buy |
200-day EMA: | 18.04 | Buy |
Arcus Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 53.54 | Buy |
Chaikin Money Flow: | 655784 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.37 - 19.47) | Sell |
Bollinger Bands (100): | (14.96 - 18.5) | Buy |
Arcus Biosciences Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arcus Biosciences Stock
Is Arcus Biosciences Stock a Buy?
- Arcus Biosciences share price is 18.21 while RCUS 8-day simple moving average is 17.13, which is a Buy signal.
- The stock price of RCUS is 18.21 while Arcus Biosciences 20-day SMA is 18.12, which makes it a Buy.
- Arcus Biosciences 50-day simple moving average is 17.05 while RCUS share price is 18.21, making it a Buy technically.
- RCUS stock price is 18.21 and Arcus Biosciences 200-day simple moving average is 17.91, creating a Buy signal.
RCUS Technical Analysis vs Fundamental Analysis
Buy
72
Arcus Biosciences (RCUS)
is a Buy
Is Arcus Biosciences a Buy or a Sell?
-
Arcus Biosciences stock is rated a Buy
The current Arcus Biosciences [RCUS] share price is $18.21. The Score for RCUS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Arcus Biosciences Stock Info
Market Cap:
1.65B
Price in USD:
18.21
Share Volume:
1.01M
Arcus Biosciences 52-Week Range
52-Week High:
25.47
52-Week Low:
12.95
Buy
72
Arcus Biosciences (RCUS)
is a Buy
Arcus Biosciences Share Price Forecast
-
What is the Arcus Biosciences stock price today?
The Arcus Biosciences stock price is 18.21 USD today. -
Will RCUS stock go up or go down?
Arcus Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Arcus Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcus Biosciences is not overvalued.
Is Arcus Biosciences Stock a Buy?
- Arcus Biosciences share price is 18.21 while RCUS 8-day exponential moving average is 17.38, which is a Buy signal.
- The stock price of RCUS is 18.21 while Arcus Biosciences 20-day EMA is 17.68, which makes it a Buy.
- Arcus Biosciences 50-day exponential moving average is 17.48 while RCUS share price is 18.21, making it a Buy technically.
- RCUS stock price is 18.21 and Arcus Biosciences 200-day simple moving average is 18.04, creating a Buy signal.
Fundamental Analysis of Arcus Biosciences
Is Arcus Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.10 per share, and a decrease next year of $0.28 per share.
Technical Analysis of Arcus Biosciences
Should I short Arcus Biosciences stock?
- RCUS Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Arcus Biosciences is a Sell
- Arcus Biosciences Relative Strength Index (RSI) is 53.54, which suggest Arcus Biosciences is overbought
- The Bollinger Bands (25) for Arcus Biosciences is (17.37 - 19.47), which suggest Arcus Biosciences is a Buy
- The Bollinger Bands (100) for Arcus Biosciences is (14.96 - 18.5), which suggest Arcus Biosciences is a Buy
* Arcus Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.